119 related articles for article (PubMed ID: 8286194)
1. Induction of transforming growth factor beta in hormonally treated human prostate cancer.
Muir GH; Butta A; Shearer RJ; Fisher C; Dearnaley DP; Flanders KC; Sporn MB; Colletta AA
Br J Cancer; 1994 Jan; 69(1):130-4. PubMed ID: 8286194
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.
Thompson AM; Kerr DJ; Steel CM
Br J Cancer; 1991 Apr; 63(4):609-14. PubMed ID: 2021547
[TBL] [Abstract][Full Text] [Related]
4. Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer.
Knabbe C; Klein H; Zugmaier G; Voigt KD
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):137-42. PubMed ID: 8274428
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
Bang YJ; Kim SJ; Danielpour D; O'Reilly MA; Kim KY; Myers CE; Trepel JB
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3556-60. PubMed ID: 1373503
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta in benign and malignant prostate.
Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta 1 as a biomarker for prostate cancer.
Thompson TC; Truong LD; Timme TL; Kadmon D; McCune BK; Flanders KC; Scardino PT; Park SH
J Cell Biochem Suppl; 1992; 16H():54-61. PubMed ID: 1289674
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen.
Benson JR; Wakefield LM; Baum M; Colletta AA
Br J Cancer; 1996 Aug; 74(3):352-8. PubMed ID: 8695348
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
15. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
16. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
17. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.
Butta A; MacLennan K; Flanders KC; Sacks NP; Smith I; McKinna A; Dowsett M; Wakefield LM; Sporn MB; Baum M
Cancer Res; 1992 Aug; 52(15):4261-4. PubMed ID: 1322240
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
19. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
[TBL] [Abstract][Full Text] [Related]
20. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
